AstraZeneca Pharma India Limited

ASTRAZEN.BO·BSE·Healthcare

Compare

6,043.30+77.25 (+1.29%)today

At close: Oct 19, 3:24 PM IST · May be delayed up to 15 min · INR

Key statistics

Previous close5,966.05

Open5,925.00

Day range5,850.006,078.40

52-week range5,660.009,850.00

Off day high−0.58%

Off 52-week high−38.65%

Volume177

Avg. volume (3M)530

Market cap—

EPS (TTM)67.85

Forward P/E—

P/E ratio (TTM)89.07

Dividend yield0.60% (36.00)

Beta (5Y)0.23

Shares outstanding—

Short interest—

Earnings date—

Analyst target—

Profit margin6.97%

Against its peers

Compare in full ›

	ASTRAZEN.BO	IPCALAB.BO	IOLCP.NS	SUNPHARMA.BO	ABBOTINDIA.NS	APLLTD.NS
Market cap	—	482.74B	50.30B	4.19T	538.88B	153.57B
P/E (TTM)	89.1	36.9	30.0	38.4	33.4	22.2
Forward P/E	—	27.0	16.5	30.9	28.1	16.0
Price/book	17.3	6.0	2.8	5.4	11.3	2.7
Dividend yield	0.60%	0.31%	0.57%	0.97%	2.04%	1.52%
1-year change	−35.03%	+50.48%	+82.99%	−2.21%	−14.73%	−14.50%
Today	+1.29%	−0.73%	−1.65%	+0.11%	−1.25%	−0.84%

The closest companies by business and industry (Drug Manufacturers - Specialty & Generic). Prices may be delayed up to 15 min.

Related companies

Compare ›

The businesses closest to ASTRAZEN.BO's by what they do, from their descriptions, with the same industry weighted in.

Company	Mkt cap	Price	Today
Ipca Laboratories LimitedIPCALAB.BO · Drug Manufacturers - Specialty & Generic	482.74B	1,902.75	−0.73%
IOL Chemicals and Pharmaceuticals LimitedIOLCP.NS · Drug Manufacturers - Specialty & Generic	50.30B	171.36	−1.65%
Sun Pharmaceutical Industries LimitedSUNPHARMA.BO · Drug Manufacturers - Specialty & Generic	4.19T	1,747.00	+0.11%
Abbott India LimitedABBOTINDIA.NS · Drug Manufacturers - Specialty & Generic	538.88B	25,360.00	−1.25%
Alembic Pharmaceuticals LimitedAPLLTD.NS · Drug Manufacturers - Specialty & Generic	153.57B	781.30	−0.84%
Lotus Pharmaceutical Co., Ltd.1795.TW · Drug Manufacturers - Specialty & Generic	45.96B	172.50	−1.99%
BDH Industries LimitedBDH.BO · Drug Manufacturers - Specialty & Generic	2.63B	456.00	−0.90%
Aurobindo Pharma LimitedAUROPHARMA.NS · Drug Manufacturers - Specialty & Generic	926.88B	1,610.90	+2.03%

What visitors to ASTRAZEN.BO's page also look at.

Company	Mkt cap	Price	Today
PFIZER LTD.PFIZER.BO	169.44B	3,700.00	−1.66%
SANOFI INDIA LTDSANOFI.BO	65.22B	2,831.75	+0.19%
AJANTA PHARMA LTD.AJANTPHARM.BO	408.62B	3,270.65	+0.35%
ABBOTT INDIA LTD.ABBOTINDIA.BO	539.59B	25,393.50	−1.36%
ALEMBIC PHARMACEUTICALS LTD.APLLTD.BO	153.46B	780.70	−0.95%

From the 4Conservative instruments index: what each company does (its business description), its industry, size, headquarters and the markets it serves; and from a year of daily prices, which move together. Prices may be delayed up to 20 min.

Latest news

All ASTRAZEN.BO news ›

Kalkine India·6d ago

AstraZeneca Pharma India ESG Rating 73 FY2025-26

Kalkine India AstraZeneca Pharma India (NSE:ASTRAZEN): What Does Its ESG Rating of 73 Mean? Source: Krish Capital Pty Ltd AstraZeneca Pharma India Limited (NSE:ASTRAZEN) disclosed on 16 October 2026 that NSE Sustainability Ratings and…

From articles in the 4Search news index.

In the news

2mentions in 30 days

2with it in the headline

Negativesentiment

Most coverage from

kalkine.co.in1
scanx.trade1

Finance and business coverage in the 4Conservative news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 2 articles, not a forecast.

About

Profile ›

AstraZeneca Pharma India Limited, a biopharmaceutical company, manufactures, markets, and trades in pharmaceutical products in India and internationally. It provides medicines for cancers, including pancreatic cancer, certain blood cancers, and cancers within breast, lung, ovary, and prostate; rare diseases; and cardiovascular, renal and metabolism, and respiratory and immunology, as well as diabetes. The company serves distributors, hospitals, and government institutions. The company was incorporated in 1979 and i…

SectorHealthcare

IndustryDrug Manufacturers - Specialty & Generic

Employees600

HeadquartersBengaluru, India

Websiteastrazeneca.in

Quarterly results

Financials ›

Revenue
Net income
Net margin 5.6% (Q2 '26)

Prices may be delayed up to 15 min. Not investment advice.

Track record

Leaderboard ›

Days on the list	30 d	1 yr	Best
Trending	0	0	—

Not eligible for Gainers, Losers, Most active (U.S. stocks worth $2 billion or more only).

Not eligible for Small-cap gainers, Aggressive small caps (U.S. stocks worth under $2 billion only).

Not eligible for Growth tech (U.S. technology stocks only).

Not eligible for Undervalued large caps (U.S. stocks worth $10 billion or more only).

A day counts when it ranked in the top 25 of a list. Tracked since Oct 10, 2026.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4Conservative index. Terms of use.